Skip to content

Supplier News

Unilever to divest Skippy peanut butter brand

Unilever has agreed to sell its global Skippy peanut butter business to Hormel Foods for about $700 million. The deal, announced Thursday, includes Unilever’s Skippy manufacturing facilities in Little Rock, Ark., and Weifang, China.

AmerisourceBergen adds board member

AmerisourceBergen Corp. has elected former Campbell Soup Co. chief executive officer Douglas Conant to its board of directors. The pharmaceutical distributor said Wednesday that the addition of Conant increases the number of board directors from nine to 10.

Kraft unveils new offerings for 2013

Focusing on what it called the "taste experience," Kraft Foods Group Inc. has announced more than 40 new food and beverage items as part of its product introductions for 2013.

SymphonyIRI gets set for annual summit

Retail executives, market forecasters and others will gather in Las Vegas to give their insights into how emerging trends are shaping the consumer packaged goods industry at the 2013 SymphonyIRI Summit in April.

Dr. Pepper Snapple to launch five new TEN sodas

Next month, Dr Pepper Snapple Group plans to roll out 10-calorie versions of five of its most popular soda brands. The beverage company said Thursday that 7UP TEN, A&W TEN root beer, Sunkist TEN orange soda, Canada Dry TEN ginger ale and RC TEN Cola will be available in January at select

GSK gets FDA OK for four-strain flu vaccine

GlaxoSmithKline has received Food and Drug Administration approval for Fluarix Quadrivalent, a four-strain seasonal flu vaccine. GSK said Monday that Fluarix Quadrivalent, for adults and children age 3 and older, represents the first intramuscular vaccine to cover against four influenza strains.

Ironwood, Forest ship IBS drug

Ironwood Pharmaceuticals Inc. and Forest Laboratories Inc. have released Linzess, a medication for irritable bowel syndrome (IBS), to U.S. pharmacies.

AstraZeneca: Crestor U.S. patent is upheld

AstraZeneca reported that the Court of Appeals for the Federal Circuit has upheld a decision of the U.S. District Court in Delaware that the substance patent protecting its cholesterol-lowering drug Crestor is "valid and enforceable.

SoloHealth kiosk sees sharp rise in consumer use

SoloHealth reported that its SoloHealth Station health and wellness kiosk has seen consumer engagement surge over 200% since late summer. The company said Thursday that to date nearly 5 million consumers have interacted with the health screening kiosk, up from 2.5 million in late August.

Elite announces supply pact for phentermine API

Elite Pharmaceuticals Inc. has shored up its supply of phentermine active ingredient for the next year. The company said Thursday that it has in place an agreement with the its sole supplier of the active pharmaceutical ingredient for its product lines that include phentermine HCl tablets (37.

Markwins wraps up Physicians Formula acquisition

Markwins International has completed its purchase of Physicians Formula Holdings Inc., a deal valued at about $75 million. Markwins said Wednesday that it has acquired all of the outstanding stock of Physicians Formula for $4.90 per share in cash.

Emerson Group names new partners

The Emerson Group has named Clark Tyndall, Sue Smith and Brian Schaefer as new partners. The consumer products consulting and services firm said Tuesday that Tyndall, Smith and Schaefer will join its Partner Group.